問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of Infectious Disease

China Medical University Hospital-Taipei (在職)

Division of Infectious Disease

更新時間：2023-09-19

王任賢Wang, Jen-Hsien
  • Principal Investigator
  • Clinical Trial Experience (year) 22 years 9 個月

  • jenhsien@mail.cmuh.org.tw

Recruiting Trial

1Cases

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

王任賢

List

26Cases

2007-11-01 - 2008-12-31

Phase III

Completed

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2005-10-01 - 2006-10-01

Phase III

Not yet recruiting

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2008-01-01 - 2010-10-31

Others

Not yet recruiting

  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites

2006-02-01 - 2007-09-15

Phase IV

Completed

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2015-10-01 - 2017-07-31

Phase I/II

Completed
A Phase I-II Study of the Safety and Efficacy of a True Human Antibody, 514G3, in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus

  • Condition/Disease

    Staphylococcus Aureus bacteremia

  • Test Drug

    514G3

Participate Sites
6Sites

Terminated4Sites

陳彥旭
Kaohsiung Municipal Gangshan Hospital

未分科

2008-05-01 - 2009-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2018-01-01 - 2020-12-31

Phase III

An open label study to evaluate the immunogenicity and safety of a tetanus toxoid vaccine in volunteers, seven years of age and older

  • Condition/Disease

    tetanus

  • Test Drug

    Tetana-Tetanus toxoid vaccine

Participate Sites
2Sites

Terminated1Sites

2017-02-07 - 2017-09-05

Phase III

Safety study of AdimFlu-S Quadrivalent Inactivated Influenza Vaccine (QIS) in Healthy Subjects.

  • Condition/Disease

    Influenza

  • Test Drug

    AdimFlu-S (QIS) Influenza Vaccine

Participate Sites
2Sites

Terminated1Sites

王任賢
China Medical University Hospital-Taipei

未分科

2016-09-01 - 2018-03-31

Phase III

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC-3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia

  • Condition/Disease

    Community-Acquired Bacterial Pneumonia

  • Test Drug

    BC-3781 tablet

Participate Sites
7Sites

Terminated5Sites

2005-12-01 - 2007-12-01

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Study ended10Sites

1 2 3
聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB